QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
QQQ   289.58 (-0.54%)
AAPL   137.35 (-2.46%)
MSFT   253.14 (-0.37%)
FB   191.29 (-0.49%)
GOOGL   2,207.68 (-1.35%)
AMZN   2,146.38 (+0.19%)
TSLA   709.42 (-0.05%)
NVDA   171.24 (+1.10%)
BABA   87.69 (+0.44%)
NIO   16.66 (+5.24%)
AMD   96.67 (+0.41%)
CGC   5.87 (+5.01%)
MU   69.40 (-2.32%)
T   20.21 (-0.10%)
GE   75.74 (+0.72%)
F   12.85 (+0.55%)
DIS   103.14 (-1.11%)
AMC   13.08 (+2.51%)
PFE   50.65 (+0.50%)
PYPL   81.28 (+5.31%)
NFLX   183.48 (+3.55%)
LON:SIS

Science in Sport (SIS) Share Forecast, Price & News

GBX 60
-2.00 (-3.23%)
(As of 05/19/2022 12:00 AM ET)
Add
Compare
Today's Range
59
61
50-Day Range
54.20
65
52-Week Range
53
84
Volume
36,237 shs
Average Volume
331,501 shs
Market Capitalization
£81.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive SIS News and Ratings via Email

Sign-up to receive the latest news and ratings for Science in Sport and its competitors with MarketBeat's FREE daily newsletter.

Science in Sport logo

About Science in Sport

Science in Sport plc, together with its subsidiaries, develops, manufactures, and markets sports nutrition products for professional athletes, sports and fitness enthusiasts, and the active lifestyle community. The company offers energy bars, gels, powders, and shots; hydration products, such as gels, tablets, and powders; recovery products; supplements; and vitamins. It sells its products under the PhD Nutrition and Science in Sport brand names through retail distribution, including supermarkets and high street chains; specialist sports retailers; grocers; convenience and discount retailers; and international wholesalers, retailers, and distributors, as well as phd.com and scienceinsport.com digital platforms, third-party online sites in the United Kingdom, rest of Europe, the United States, and internationally. Science in Sport plc was founded in 1992 and is headquartered in London, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
229
Year Founded
N/A

Sales & Book Value

Annual Sales
£62.54 million
Cash Flow
GBX 3.54 per share
Book Value
GBX 33 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£81.06 million
Optionable
Not Optionable

Company Calendar

Last Earnings
9/16/2020
Today
5/19/2022

MarketRank

Overall MarketRank

1.69 out of 5 stars

Analyst Opinion: 3.5Community Rank: 4.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -













Science in Sport (LON:SIS) Frequently Asked Questions

Is Science in Sport a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Science in Sport in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Science in Sport stock.
View analyst ratings for Science in Sport
or view top-rated stocks.

How were Science in Sport's earnings last quarter?

Science in Sport plc (LON:SIS) released its quarterly earnings results on Wednesday, September, 16th. The company reported ($1.80) earnings per share for the quarter.
View Science in Sport's earnings history
.

What price target have analysts set for SIS?

1 brokerages have issued 12-month target prices for Science in Sport's shares. Their forecasts range from GBX 100 to GBX 100. On average, they anticipate Science in Sport's share price to reach GBX 100 in the next twelve months. This suggests a possible upside of 66.7% from the stock's current price.
View analysts' price targets for Science in Sport
or view top-rated stocks among Wall Street analysts.

Who are Science in Sport's key executives?
Science in Sport's management team includes the following people:
  • Mr. Stephen N. Moon, CEO & Exec. Director
  • Mr. James Lonsdale Simpson, CFO & Exec. Director (Age 48, Pay $256k)
  • Mr. Ashley Read, Chief Operating Officer
  • Ms. Muna Khan, Chief Technology Officer
  • Mr. Dwain Jackson, Head of Trading USA
  • Ms. Gemma Notarangelo, Head of CRM
What other stocks do shareholders of Science in Sport own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Science in Sport investors own include Cidara Therapeutics (CDTX), Carnival Co. & (CCL), Bellway (BWY), British American Tobacco (BTI), boohoo group (BOO), B&M European Value Retail (BME), Balfour Beatty (BBY), Alibaba Group (BABA), Advanced Oncotherapy (AVO) and ASOS (ASC).

What is Science in Sport's stock symbol?

Science in Sport trades on the London Stock Exchange (LON) under the ticker symbol "SIS."

How do I buy shares of Science in Sport?

Shares of SIS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Science in Sport's stock price today?

One share of SIS stock can currently be purchased for approximately GBX 60.

How much money does Science in Sport make?

Science in Sport has a market capitalization of £81.06 million and generates £62.54 million in revenue each year.

How many employees does Science in Sport have?

Science in Sport employs 229 workers across the globe.

What is Science in Sport's official website?

The official website for Science in Sport is www.scienceinsport.com.

How can I contact Science in Sport?

Science in Sport's mailing address is 16-18 Hatton Garden, LONDON, EC1N 8AT, United Kingdom. The company can be reached via phone at +44-1282-440980.

This page was last updated on 5/19/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.